Ex Parte Akashe et al - Page 6



          Appeal No. 2005-2629                                                        
          Application No. 10/377,474                                                  

               Appellants also contend that "given the fact that soy                  
          protein is only an optional ingredient, such option suggests that           
          the levels of the soy protein in Cope may not effect [sic,                  
          affect] the stability of the composition" (page 11 of principal             
          brief, third paragraph).  However, as noted by the examiner, Cope           
          exemplifies an aqueous emulsion comprising soy protein.                     
               Appellants rely upon Examples 3 and 4 of the present                   
          specification to demonstrate that soy protein does not exhibit an           
          anti-oxidative effect in all compositions.  Example 3 shows that            
          soy protein has no anti-oxidative effect when added to bulk oil             
          rather than an emulsion, whereas Example 4 "shows that the soy              
          protein has limited antioxidative effect without naturally                  
          occurring isoflavones" (page 3 of Reply Brief, last paragraph).             
          However, these examples are not probative to the issue of whether           
          the soy protein of Cope exhibits an anti-oxidative effect on the            
          disclosed aqueous emulsions which comprise omega-3 poly-                    
          unsaturated lipids.                                                         
               Turning to the § 103 rejection of claims 1-18 over Cope in             
          view of Chang, it logically follows that our rationale in support           
          of sustaining the examiner's § 102 rejection over Cope is also              
          applicable to affirming the examiner's § 103 rejection.                     


                                         -6-                                          



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007